Development of a practical synthesis of etravirine via a microwave-promoted amination
Abstract Background Etravirine (ETV) was approved as the second generation drug for use in individuals infected with HIV-1 in 2008 by the U.S. FDA with its unique antiviral activity, high specificity, and low toxicity. However, there are some shortcomings of the existing synthetic routes, such as th...
Main Authors: | Da Feng, Fenju Wei, Zhao Wang, Dongwei Kang, Peng Zhan, Xinyong Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | Chemistry Central Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13065-018-0504-4 |
Similar Items
-
Etravirine Pharmacokinetics In HIV-Infected Pregnant Women
by: Nikki Mulligan, et al.
Published: (2016-08-01) -
A Review Concerning the Use of Etravirine and Darunavir in Translational Medicine
by: Mariana Pereira, et al.
Published: (2023-10-01) -
A Pilot Phase 2 Randomized Trial to Evaluate the Safety and Potential Efficacy of Etravirine in Friedreich Ataxia Patients
by: Gabriella Paparella, et al.
Published: (2024-08-01) -
The results of the use of etravirine within 48 weeks in patients in Saint-Petersburg in real clinical practice
by: N. V. Sizova, et al.
Published: (2022-04-01) -
Fabrication of TPGS decorated Etravirine loaded lipidic nanocarriers as a neoteric oral bioavailability enhancer for lymphatic targeting
by: Abdul Muheem, et al.
Published: (2024-01-01)